Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts.
Viruses. 2023 Aug 29;15(9):1828. doi: 10.3390/v15091828.
Viruses. 2023.
PMID: 37766235
Free PMC article.
Clinical Trial.
[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
Mazurkova NA, Ryndiuk NN, Shishkina LN, Ternovoĭ VA, Tumanov IuV, Bulychev LE, Skarnovich MO, Kabanov AS, Panchenko SG, Aleĭnikov RP, Il'ina TN, Kuzubov VI, Mel'nikov SIa, Mironov AN, Korovkin SA, Sergeev AN, Drozdov IG.
Mazurkova NA, et al. Among authors: kuzubov vi.
Vestn Ross Akad Med Nauk. 2010;(3):15-20.
Vestn Ross Akad Med Nauk. 2010.
PMID: 20422755
Clinical Trial.
Russian.
Item in Clipboard
[Evaluation of immunogenicity and safety of 2 immunizations with allantoic intranasal live influenza vaccine Ultragrivac].
Shishkina LN, Mazurkova NA, Ternovoĭ VA, Bulychev LE, Tumanov IuV, Skarnovich MO, Kabanov AS, Ryndiuk NN, Kuzubov VI, Mironov AN, Stavskiĭ EA, Drozdov IG.
Shishkina LN, et al. Among authors: kuzubov vi.
Zh Mikrobiol Epidemiol Immunobiol. 2011 Jul-Aug;(4):92-6.
Zh Mikrobiol Epidemiol Immunobiol. 2011.
PMID: 21916043
Clinical Trial.
Russian.
Item in Clipboard
Cite
Cite